SCHEMBL7053112

SCHEMBL7053112

NCCC(Oc1ccc(F)cc1)c1ccccc1

nearest known ligand 0.70

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 4/20 0.70
SLC6A2 P23975 2/20 0.70
SLC6A3 Q01959 2/20 0.70
KCNK2 O95069 1/20 0.70
KCNH2 Q12809 1/20 0.70
CACNA1C Q13936 1/20 0.70
SLC7A5 Q01650 11/20 0.57
HTR1A P08908 1/20 0.48
ALDH1A1 P00352 1/20 0.48
CYP2D6 P10635 1/20 0.48
MAPT P10636 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
SLC6A9 P48067 1/20 0.48
SLC6A5 Q9Y345 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL7409520 0.93 SLC6A4 (0.62) SLC6A4SLC6A2SLC6A3KCNK2KCNH2
SCHEMBL17278097 0.89 SLC7A5 (0.72) SLC6A4SLC6A2SLC6A3KCNK2KCNH2
Maleic Acid SCHEMBL7312415 0.89 SLC6A4 (0.58) SLC6A4SLC6A2SLC6A3KCNK2KCNH2
Fumaric Acid SCHEMBL7312427 0.89 SLC6A4 (0.58) SLC6A4SLC6A2SLC6A3KCNK2KCNH2
SCHEMBL1045800 0.88 SLC6A4 (0.71) SLC6A4SLC6A2SLC6A3KCNK2KCNH2
SCHEMBL350781 0.86 SLC6A4 (0.60) SLC6A4SLC6A2SLC6A3KCNK2KCNH2
Hydrochloric Acid SCHEMBL6527457 0.84 SLC6A4 (0.67) SLC6A4SLC6A2SLC6A3KCNK2KCNH2
SCHEMBL5405168 0.83 SLC6A4 (0.66) SLC6A4SLC6A2SLC6A3KCNK2KCNH2
SCHEMBL7056008 0.83 SLC6A4 (0.66) SLC6A4SLC6A2SLC6A3KCNK2KCNH2
SCHEMBL684955 0.83 SLC6A4 (0.66) SLC6A4SLC6A2SLC6A3KCNK2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0831799-B1 COMPOUNDS ACTIVE AT A NOVEL SITE ON RECEPTOR-OPERATED CALCIUM CHANNELS USEFUL FOR TREATMENT OF NEUROLOGICAL DISORDERS NPS PHARMA INC (US) 2003-05-02 EP claimed
EP-0831799-B1 COMPOUNDS ACTIVE AT A NOVEL SITE ON RECEPTOR-OPERATED CALCIUM CHANNELS USEFUL FOR TREATMENT OF NEUROLOGICAL DISORDERS NPS PHARMA INC (US) 2003-05-02 EP disclosed